AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.42
+0.04 (0.43%)
Dec 5, 2025, 4:00 PM EST - Market closed
AdaptHealth Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 13.6, with a low estimate of 11 and a high estimate of 16. The average target predicts an increase of 44.37% from the current stock price of 9.42.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for AdaptHealth stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +59.24% | Nov 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +38.00% | May 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +38.00% | May 8, 2025 |
| Baird | Baird | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +69.85% | Feb 27, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +48.62% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
3.29B
from 3.26B
Increased by 0.89%
Revenue Next Year
3.52B
from 3.29B
Increased by 6.84%
EPS This Year
0.82
from 0.61
Increased by 34.33%
EPS Next Year
1.13
from 0.82
Increased by 38.02%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.4B | 3.8B | |
| Avg | 3.3B | 3.5B | |
| Low | 3.2B | 3.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 4.5% | 14.7% | |
| Avg | 0.9% | 6.8% | |
| Low | -3.3% | -0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.99 | 1.39 | |||
| Avg | 0.82 | 1.13 | |||
| Low | 0.65 | 0.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 61.8% | 69.1% | |||
| Avg | 34.3% | 38.0% | |||
| Low | 6.0% | 4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.